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Despite the availability of effective treatment for
tuberculosis for decades, the global burden of 
tuberculosis cases is increasing.1 It is estimated
that 1.8 million patients die of tuberculosis world-
wide every year.1,2 In the year 2002, there were an
estimated 8.8 million (141 per 100,000) new cases
of tuberculosis, of which 3.9 million (63 per
100,000) were smear-positive.3 Early diagnosis
and adequate treatment of infectious pulmonary
tuberculosis patients are essential to reducing
transmission of tuberculosis and lead to its ulti-
mate elimination. An effective national tuberculo-
sis program (NTP) is defined as one that has a high
treatment success rate, a low level of acquired
drug resistance and a high case detection rate.4
The two targets for global tuberculosis control
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Treatment Outcome of Pulmonary
Tuberculosis in Eastern Taiwan—
Experience at a Medical Center
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Background/Purpose: The World Health Organization (WHO) has proposed that treatment outcome is an
important indicator of tuberculosis control. This study investigated the outcome of tuberculosis treatment
at a medical center in eastern Taiwan.
Methods: A total of 166 pulmonary tuberculosis patients notified by Tzu Chi Hospital in 2002 were included
in this study. Treatment outcome data were collected at the local level and categorized according to WHO
recommendations as cured, treatment completed, failed, died, defaulted, or transferred. Outcomes of the
166 patients, as reported by the National Tuberculosis Program were obtained from the Taiwan Center for
Disease Control (Taiwan CDC) for comparison.
Results: Of the 166 patients, outcome was classified as cured in 46 (27.7%), treatment completed in 73
(44.0%), died in 27 (16.3%), treatment failed in five (3.0%), and defaulted in 15 (9.0%). Males were more
likely to die or to default than females, and the elderly were more likely to die than younger patients. Patients
with comorbidities were significantly more likely to die than patients without (p = 0.025). Patients with a
history of tuberculosis were more likely to default (p = 0.050). Smear-positive patients were more likely 
to fail, and patients without cavitation on chest radiograph were more likely to have successful treatment.
Outcomes of 26 (15.7%) cases in this cohort were unavailable (18 cases) or inaccurate (8 cases) on the
Taiwan CDC website.
Conclusion: The unsatisfactory outcome of pulmonary tuberculosis treatment in this medical center in
eastern Taiwan highlights the importance of implementing directly observed treatment short course strategy.
Improvement in the quality of data reported by the National Tuberculosis Program is urgently needed.
[J Formos Med Assoc 2007;106(1):25–30]
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ratified by the 1991 World Health Assembly
were: (1) to detect 70% of new smear-positive
cases; and (2) to successfully treat 85% of these
cases.5 The 1.4 million smear-positive cases noti-
fied by directly observed treatment short course
(DOTS) programs in 2002 worldwide repre-
sented 37% of the estimated incidence, achiev-
ing 53% of the target of 70% case detection rate.
Treatment success in the 2002 global cohort was
82%, close to the target of 85%, but not higher
than the previous two annual cohorts.6
The Taiwan Center for Disease Control (CDC)
reported 16,758 notifiable cases in 2002 in
Taiwan.7 The notification rate of confirmed tuber-
culosis cases was 74.6 per 100,000 (100.6 for
males; 47.6 for females). The mortality rate was
5.7 per 100,000. In eastern Taiwan, the notifica-
tion rate and mortality rate were higher (155.8 per
100,000 and 15.8 per 100,000 each) than the na-
tional rates.8 Tuberculosis treatment success rates
reported by the NTP between 2000 and 2002
ranged from 73.8% to 78.3%.8 Failure to achieve
an 85% successful treatment rate was partly due to
the high case fatality rate (17.8–21%). The objec-
tive of this study was to analyze treatment out-
come of pulmonary tuberculosis cases reported at
Tzu Chi Medical Center in eastern Taiwan and to
compare the results with data reported in Taiwan
and worldwide.
Methods
A total of 215 tuberculosis cases were reported to
the Taiwan CDC by Tzu Chi Medical Center in
2002. Of the 215 cases, 21 were extrapulmonary
tuberculosis cases and 28 had a subsequent diag-
nosis of non-tuberculous disease and were thus
excluded. The remaining 166 patients comprised
the study population. Patients were treated with
a 6-month rifampicin-containing regimen, con-
sisting of isoniazid, rifampicin, ethambutol and
pyrazimide for 2 months followed by isoniazid,
rifampicin, and ethambutol for an additional 4
months. The regimen was later changed to sec-
ond line antituberculosis drugs in eight patients
because of multidrug-resistant tuberculosis (6),
drug fever (1) and drug-induced hepatitis (1).
Drugs were self-administered by patients. Public
health nurses visited patients from time to time
to supervise treatment. Of the 166 patients, 123
(74.1%) were admitted for a mean of 24 days
(range, 1–176 days).
Charts were reviewed to obtain the follow-
ing information: age, sex, race (aboriginal or
non-aboriginal), previous history of tubercu-
losis, results of sputum smear for acid fast bacilli 
and culture for Mycobacterium tuberculosis, cavita-
tions on chest radiograph, and concurrent dis-
eases such as diabetes mellitus, cancer, liver
cirrhosis, uremia, pneumoconiosis, AIDS, and
steroid use.
Pulmonary tuberculosis cases were classified
as definite or probable. A definite case was 
defined as a patient with a positive sputum culture
for M. tuberculosis. A probable case was defined as 
a patient who was sputum culture negative, but
whose clinical and chest radiographic manifesta-
tions led to a clinical decision to commence a full
course of antituberculosis therapy.4 Both groups of
tuberculosis patients were required to be reported
to the Taiwan CDC.
The treatment outcomes of pulmonary tuber-
culosis patients were defined as follows.3 Cured
was defined as a patient who was sputum culture
negative in the last month of treatment and on at
least one previous occasion. Treatment completed
was defined as a patient who had completed treat-
ment but who did not meet the criteria to be
classified as cured or failed. Failed was defined as
a patient who remained or became sputum cul-
ture positive again at 5 months or later during
treatment. Died was defined as a patient who died
for any reason during the course of treatment.
Defaulted was defined as a patient whose treat-
ment was interrupted for 2 consecutive months 
or more. Transferred out was defined as a patient
who had been transferred to another recording/
reporting unit and whose treatment outcome
was not known. Successfully treated was defined
as a patient who was cured or had completed
treatment.
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Treatment outcomes were determined 18
months after the close of the year (2002) in
which these cases were registered. Treatment out-
come data were collected at the local level and
confirmed by a tuberculosis specialist at Tzu Chi
Medical Center. To evaluate the accuracy of out-
comes reported by the NTP, data on the outcomes
of enrolled patients were obtained from the 
website of the national tuberculosis registry in
July 2004.
Statistical analysis
Statistical analysis was performed using STATA
version 8.0 (STATA Corp., Houston, TX, USA).
The χ2 test was used to determine the association
of categorical variables. A p value < 0.05 was 
considered to be statistically significant.
Results
Table 1 shows the characteristics of the 166 
patients. Of the 166 patients, 128 (77.1%) were
male, 155 (93.4%) had never previously been
treated with antituberculosis drugs for as long 
as 1 month, 127 (76.5%) were definite cases, 
62 (37.3%) were smear-positive and 79 (47.6%)
were aboriginals. The mean age of patients was
52.2 years (range, 5–90 years). No patient tested
positive for HIV, but 55 (33.1%) patients had
concurrent diseases, including diabetes mellitus
(32), cancer (13), liver cirrhosis (3), uremia (3),
pneumoconiosis (2), gastrectomy (1), and diseases
requiring long-term steroid treatment (1).
Of the 166 patients, 46 (27.7%) were classi-
fied as cured, 73 (44.0%) as treatment com-
pleted, 27 (16.3%) as died, five (3.0%) as failed,
and 15 (9.0%) as defaulted. Outcomes of all 166
were determined. Therefore, none of the patients 
were classified as transferred. The proportion of 
patients with successful treatment was 71.7%.
Table 2 shows the treatment outcomes of the 166
patients determined by this study as compared
with those posted on the Taiwan CDC website
accessed in July 2004. Outcomes of 26 (15.7%)
cases were unavailable (18 cases) or inaccurate
(8 cases) on the CDC website. Of the 18 cases
whose outcomes were unavailable on the CDC
website, one was classified as cured, three as
treatment completed, four as failed and 10 as 
defaulted. The diagnosis of two bacteriologically
confirmed cases was inaccurately changed to
non-tuberculosis diseases on the website; our
study revealed that these two cases had success-
ful treatment. Two cases reported as treatment
success on the website had interrupted treatment
for > 2 months (defaulted). Four patients were
reported as having died on the website, but our
investigation showed that one had failed treat-
ment and three had been successfully treated.
Table 3 shows the factors associated with treat-
ment outcome. Males were more likely to die and
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Table 1. Characteristics of 166 pulmonary
tuberculosis patients
n (%)
Age (yr)
< 24 22 (13.3)
25–44 39 (23.5)
45–64 51 (30.7)
≥ 65 54 (32.5)
Sex
Male 128 (77.1)
Female 38 (22.9)
Aboriginal
Yes 79 (47.6)
No 87 (52.4)
Sputum smear
Positive 62 (37.3)
Negative 104 (62.7)
Sputum culture
Positive 127 (76.5)
Negative 39 (23.5)
Type of patient
Never previously been treated 155 (93.4)
for as long as 1 mo
Retreatment 11 (6.6)
Concurrent disease
Yes 55 (33.1)
No 111 (66.9)
default than females, and the elderly were more
likely to die than younger patients, but these 
associations were not statistically significant. The
proportion of patients with treatment success was
similar among the aboriginal and non-aboriginal
subpopulations, but the aboriginal subpopulation
was slightly more likely to fail or default. Patients
with comorbidities were significantly more likely
to die than patients without (p = 0.025). Patients
with a history of tuberculosis were more likely to
default than patients without (p = 0.050). Smear-
positive patients were more likely to fail than
smear-negative patients, and patients without cav-
itation on chest X-ray were more likely to have
successful treatment than patients with, but these
associations were not significant.
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Table 2. Comparison of treatment outcomes of the 166 pulmonary tuberculosis patients determined in this study with their
outcomes as posted on the Taiwan Center for Disease Control (CDC) website8
Treatment success Died Failed Defaulted Changing diagnosis Not evaluated
This study (n) 119 27 5 15 0 0
CDC website (n) 112 31 0 3 2 18
Table 3. Treatment outcome by sex, age group, aboriginal race, concurrent disease, history of tuberculosis, results of 
sputum examination, and the presence of cavitation on chest radiography
Total (n) Treatment success (%) Died (%) Failed (%) Defaulted (%) p
Sex 0.530
Male 128 69.5 17.2 3.9 9.4
Female 38 79.0 13.2 0 7.9
Age (yr) 0.114
< 24 22 86.4 0 0 13.6
25–44 39 76.9 7.7 5.1 10.3
45–64 51 72.6 17.7 3.9 5.9
≥ 65 54 61.1 27.8 1.9 9.3
Aboriginal 0.797
No 87 71.3 18.4 2.3 8.1
Yes 79 72.2 14.0 3.8 10.1
Concurrent disease 0.025
Yes 55 65.5 27.3 0 7.3
No 111 74.8 10.8 4.5 9.9
History of tuberculosis* 0.050
Yes 11 63.6 0 9.1 27.3
No 155 72.3 17.4 2.6 7.8
Sputum examination results 0.303
M+/C+ 62 72.6 12.9 6.5 8.1
M–/C+ 65 66.2 20.0 1.5 12.3
M–/C– 39 79.5 15.4 0 5.1
Cavitation on CXR 0.871
Yes 53 67.9 18.9 3.8 9.4
No 108 74.1 14.8 2.8 8.3
*History of tuberculosis treatment for as long as 1 month. M = smear; C = culture; + = positive; − = negative; CXR = chest X-ray.
Discussion
This study found that the treatment outcome of
tuberculosis patients diagnosed at the Tzu Chi
Medical Center was unsatisfactory. The successful
treatment rate in this cohort of patients was only
71.7%, and the successful treatment rate of all
cases registered in 2002 reported by the Taiwan
CDC was 78.3%.8 The low successful treatment
rate was partly due to a high fatality rate (16.3%),
but the high treatment default (9.0%) rate de-
serves special attention. Strengthening case hold-
ing to reduce treatment interruption should be
among the top priority of NTPs.
This study demonstrated that a high case 
fatality rate of tuberculosis patients was signifi-
cantly associated with concomitant disease, and,
although not significantly, old age. Further study
with a larger sample size is necessary to determine
the causes of the high case fatality rate of tubercu-
losis patients in Taiwan. Although the proportion
of patients with treatment success was almost the
same among aboriginal and non-aboriginal sub-
populations, the aboriginal subpopulation was
slightly more likely to fail or default. Whether a
higher prevalence of tuberculosis among aborigi-
nals9 than among non-aboriginals was due to a
higher failed and default rate among aboriginal
patients needs to be further investigated.
Patients with a history of tuberculosis were
more likely to interrupt treatment. Although data
on the outcomes of these patients’ previous treat-
ment were not available, it is likely that they also
experienced an interruption of treatment in a
previous episode of tuberculosis.10 Clearly, the
NTP needs to pay greater attention to retreatment
of tuberculosis patients.
The cohort of patients enrolled in this study
was registered in the year 2002. As the outcome
of treatment was determined in July 2004, there
was sufficient time to obtain outcome informa-
tion. Unfortunately, the results for 18 individu-
als had yet to be evaluated by the NTP in July
2004 according to the information posted on the
Taiwan CDC website. Furthermore, the treatment
outcome of some patients determined by the
NTP was inaccurate. This reflects the inability 
of the NTP to obtain precise and accurate treat-
ment information in a timely manner. Clearly, the
NTP should strengthen the link between public
health workers and health institutions providing
tuberculosis services to facilitate the collection of
information.
Table 4 compares the treatment outcomes of
tuberculosis cases registered in 2000–2002 in
Taiwan with those of cases included in this study
and with those of the WHO 2005 report on global
tuberculosis control.6 The treatment success rates
under the DOTS programs among 22 high-burden
countries (HBCs) varied from 60% in Uganda to
93% in China, with an average of 83%. The treat-
ment success rate of 71.7% in this study was
slightly lower than the rates of 73.8% reported in
2001 and 78.3% in 2002 in Taiwan. The case fatal-
ity rate among 22 HBCs was, on average, 4.6%,
and ranged from 13% in the Russian Federation,
partly due to drug resistance, AIDS or old age, 
to 1.3% in China. The proportion of patients
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Table 4. Comparison of treatment outcomes of tuberculosis cases in 2000–2002 in Taiwan, in this study, and the results of
the WHO report on global tuberculosis control
Treatment success Died Failed Defaulted Transferred Not evaluated
Taiwan 20008 74.2 18.3 0.2 7.0 0.3 0
Taiwan 20018 73.8 20.1 0.4 5.2 0.6 0
Taiwan 20028 78.3 17.8 0.4 3.2 0.4 0
This study 2002 71.7 16.3 3.0 9.0 0 0
Global 2002, non-DOTS6 68.0 3.7 2.0 16.0 6.9 2.9
Global 2002, DOTS6 82.0 4.8 1.6 6.7 3.4 1.4
DOTS = directly observed treatment short course.
who defaulted was on average 6.2% among the
22 HBCs, ranging from 19% in Uganda to 1.0%
in China. The default rate in this study (9.0%)
was higher than 5%, indicating the necessity of
strengthening defaulter tracing.11 The treatment
failure rate varied from 0.1% in Zimbabwe to
9.1% in the Russian Federation, with an average
of 1.5% in HBCs. The treatment failure rate in
this study was 3.0%, two times higher than the
average of the HBCs. Surprisingly, the treatment
outcome of tuberculosis in Taiwan was worse
than that of HBCs under the DOTS program.
Directly observed therapy (DOT) during at
least the first 2 months of treatment, in which pa-
tients take drugs directly under the observation of
health care providers, has been recommended by
international tuberculosis authorities,12,13 and has
been shown to be effective in achieving a high
successful treatment rate, from 86% to 96.5%.14
The utility of DOT has also been demonstrated
in developed countries. Jasmer et al reported that
DOT was significantly associated with a higher
treatment success rate than self-administered
therapy (97.8% vs. 88.6%, p < 0.002) and a lower
tuberculosis-related mortality rate (0% vs. 5.5%,
p = 0.002).15 DOT also leads to significant reduc-
tions in the frequency of primary drug resistance,
acquired drug resistance and relapse.16
We conclude that the treatment success rate of
pulmonary tuberculosis treated at this medical
center in eastern Taiwan was unsatisfactorily low
(71.7%). A high proportion of patients failed (3%)
or defaulted (9%), which is a serious public health
concern that needs to be addressed urgently. To
improve this situation, we strongly recommend
implementing the DOTS strategy in Taiwan.
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